Table 1.
Demography (intent-to-treat population)
| SE-implant (N = 197) | FE-implant (N = 200) | Timolol (N = 193) | Total (N = 590) | |
|---|---|---|---|---|
| Age (years) | ||||
| Mean (SD) | 63.2 (12.6) | 63.8 (11.5) | 63.8 (11.4) | 63.6 (11.8) |
| Min, max | 24, 89 | 22, 86 | 28, 94 | 22, 94 |
| Sex, n (%) | ||||
| Male | 98 (49.7) | 91 (45.5) | 85 (44.0) | 274 (46.4) |
| Female | 99 (50.3) | 109 (54.5) | 108 (56.0) | 316 (53.6) |
| Race, n (%) | ||||
| White | 120 (60.9) | 143 (71.5) | 128 (66.3) | 391 (66.3) |
| Black or African American | 50 (25.4) | 38 (19.0) | 41 (21.2) | 129 (21.9) |
| Asian | 19 (9.6) | 15 (7.5) | 16 (8.3) | 50 (8.5) |
| Native Hawaiian or Pacific Islander | 0 | 1 (0.5) | 0 | 1 (0.2) |
| American Indian or Alaska Native | 0 | 0 | 2 (1.0) | 2 (0.3) |
| Other or unknown | 8 (4.1) | 3 (1.5) | 6 (3.1) | 17 (2.9) |
| Ethnicity, n (%) | ||||
| Hispanic or Latino | 15 (7.6) | 9 (4.5) | 10 (5.2) | 34 (5.8) |
| Not Hispanic or Latino | 179 (90.9) | 191 (95.5) | 180 (93.3) | 550 (93.2) |
| Unknown | 3 (1.5) | 0 | 3 (1.6) | 6 (1.0) |
FE-implant fast-eluting travoprost intracameral implant, ITT intent-to-treat, SD standard deviation, SE-implant slow-eluting travoprost intracameral implant